Custom Search

Friday, February 2, 2007


Adult Stem Cell Biotech and Industry

One of the most famous companies is Osiris Therapeutics Inc.
The above chart shows you that the stock price of Osiris Therapeutics has been doubled since its IPO (inital public offering) on Aug 4, 2006, from about $10 to more than $20 a share. This happened only in less than 6 months! Don't you think stem cell biotech is a good investment opportunity?
Osiris Therapeutics has three products in clinical trials:
This company is expanding and recruiting many new employees, particularly technicians and scientists. Good chances for biology masters and Ph.Ds to jump into stem cell industry!

Source: CNN money
As an investor, Stem Cell Stocks look's an article i found about Stem Cell Stocks...

Investing in Stem Cell Stocks

Post a Comment

Subscribe to Post Comments [Atom]

<< Home

This page is powered by Blogger. Isn't yours?

Subscribe to Posts [Atom]